J. Cassataro

C. A. Fossati, J. Cassataro, Karina A. Pasquevich, 2020, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

A Brucella spp. Protease Inhibitor Limits Antigen Lysosomal Proteolysis, Increases Cross-Presentation, and Enhances CD8+ T Cell Responses

M. Tkach, R. Schillaci, A. Trevani, 2016, The Journal of Immunology.

The Trypanosoma cruzi TcTASV-C protein subfamily administrated with U-Omp19 promotes a protective response against a lethal challenge in mice.

D. Sánchez, V. Tekiel, J. Cassataro, 2020, Vaccine.

Oral co-administration of a bacterial protease inhibitor in the vaccine formulation increases antigen delivery at the intestinal epithelial barrier

Francisco Guaimas, J. Cassataro, Karina A. Pasquevich, 2019, Journal of controlled release : official journal of the Controlled Release Society.

A disordered region retains the full protease inhibitor activity and the capacity to induce CD8+ T cells in vivo of the oral vaccine adjuvant U-Omp19

Lucía B. Chemes, Rodolfo M. Rasia, J. Cassataro, 2022, Computational and structural biotechnology journal.

U-Omp19 from Brucella abortus increases dmLT immunogenicity and improves protection against Escherichia coli heat-labile toxin (LT) oral challenge

J. Cassataro, Karina A. Pasquevich, Lorena M. Coria, 2020, Vaccine.

Oral delivery of Brucella spp. recombinant protein U-Omp16 abrogates the IgE-mediated milk allergy

C. A. Fossati, J. Cassataro, A. Ibañez, 2014, Human vaccines & immunotherapeutics.

Antibody Reactivity to Omp31 from Brucella melitensis in Human and Animal Infections by Smooth and Rough Brucellae

C. A. Fossati, P. Baldi, J. Cassataro, 2004, Clinical Diagnostic Laboratory Immunology.

Antibodies to the CP24 protein of Brucella melitensis lack diagnostic usefulness in ovine brucellosis.

M. Delpino, C. A. Fossati, P. Baldi, 2003, Veterinary microbiology.

Diagnostic Usefulness of Antibodies against Ribosome Recycling Factor from Brucella melitensis in Human or Canine Brucellosis

M. Delpino, C. A. Fossati, P. Baldi, 2002, Clinical and Vaccine Immunology.

Stability Studies of the Vaccine Adjuvant U-Omp19

J. Cassataro, Karina A. Pasquevich, Laura A. Bruno, 2020, Journal of pharmaceutical sciences.

Immunogenicity of the Brucella melitensis recombinant ribosome recycling factor-homologous protein and its cDNA.

M. Spitz, A. Cloeckaert, S. Estein, 2002, Vaccine.

Brucella abortus induces apoptosis of human T lymphocytes.

M. Delpino, G. Giambartolomei, P. Barrionuevo, 2012, Microbes and infection.

Immunization with Murine Breast Cancer Cells Treated with Antisense Oligodeoxynucleotides to Type I Insulin-Like Growth Factor Receptor Induced an Antitumoral Effect Mediated by a CD8+ Response Involving Fas/Fas Ligand Cytotoxic Pathway1

M. Rivas, Cecilia J. Proietti, P. Elizalde, 2006, The Journal of Immunology.

Cytotoxic Pathway Response Involving Fas/Fas Ligand + CD8Induced an Antitumoral Effect Mediated by a Type I Insulin-Like Growth Factor Receptor to Treated with Antisense Oligodeoxynucleotides Immunization with Murine Breast Cancer Cells

M. Rivas, R. Schillaci, G. Giambartolomei, 2006 .

Induced an Antitumoral Effect Mediated by a Type I Insulin-Like Growth Factor Receptor to Treated with Antisense Oligodeoxynucleotides Immunization with Murine Breast Cancer Cells

M. Rivas, R. Schillaci, G. Giambartolomei, 2006 .

Brucella abortus activates human neutrophils.

M. Delpino, G. Giambartolomei, P. Barrionuevo, 2009, Microbes and infection.

Unlipidated Outer Membrane Protein Omp16 (U-Omp16) from Brucella spp. as Nasal Adjuvant Induces a Th1 Immune Response and Modulates the Th2 Allergic Response to Cow’s Milk Proteins

S. Oliveira, M. Delpino, C. A. Fossati, 2013, PloS one.

Safety, tolerability, and immunogenicity of a new SARS-CoV-2 recombinant Gamma variant RBD-based protein adjuvanted vaccine, used as heterologous booster in healthy adults: a Phase 1 interim report.

J. Vega, A. Ceballos, J. Geffner, 2023, medRxiv.

Evaluation of the Efficacy of Outer Membrane Protein 31 Vaccine Formulations for Protection against Brucella canis in BALB/c Mice

S. Estein, G. Giambartolomei, J. Cassataro, 2014, Clinical and Vaccine Immunology.

The vaccine candidate BLSOmp31 protects mice against Brucella canis infection.

F. Goldbaum, S. Estein, G. Giambartolomei, 2013, Vaccine.

A bacterial protease inhibitor protects antigens delivered in oral vaccines from digestion while triggering specific mucosal immune responses.

F. Frank, G. Briones, F. Goldbaum, 2015, Journal of controlled release : official journal of the Controlled Release Society.

Brucella lipoproteins mimic dendritic cell maturation induced by Brucella abortus.

M. Delpino, C. A. Fossati, G. Giambartolomei, 2008, Microbes and infection.

and Oral Acquired Brucellosis Self-Adjuvanting Vaccine against Systemic Th1 Immune Response, and Is a Promising Activates Dendritic Cells In Vivo, Induces a Pathogen-Associated Molecular Pattern That Membrane Protein 16 Is a New Bacterial Outer Brucella abortus The Protein Moiety of

Fernanda S. Oliveira, J. Borkowski, H. Warzecha, 2017 .

Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB/c mice.

M. Delpino, S. Estein, P. Baldi, 2007, Vaccine.

A Novel Bacterial Protease Inhibitor Adjuvant in RBD-Based COVID-19 Vaccine Formulations Containing Alum Increases Neutralizing Antibodies, Specific Germinal Center B Cells and Confers Protection Against SARS-CoV-2 Infection in Mice

D. Alvarez, Julieta Alcain, J. Cassataro, 2022, Frontiers in Immunology.

Evaluation of the efficacy of Outer Membrane Protein 31vaccine formulations for protection

S. Estein, J. Cassataro, A. Ibañez, 2014 .

Brucella abortus inhibits IFN-γ-induced FcγRI expression and FcγRI-restricted phagocytosis via toll-like receptor 2 on human monocytes/macrophages.

M. Delpino, G. Giambartolomei, P. Barrionuevo, 2011, Microbes and infection.

A DNA Vaccine Coding for the Brucella Outer Membrane Protein 31 Confers Protection against B. melitensis and B. ovis Infection by Eliciting a Specific Cytotoxic Response

S. Estein, G. Giambartolomei, J. Cassataro, 2005, Infection and Immunity.

Formulation Used 544 Independently of the Adjuvant abortus Brucella Infection in Mice Challenged with Th 1-Th 2 Immune Response and Reduces Lumazine Synthase Elicits a Mixed Brucella

F. Goldbaum, S. Estein, G. Giambartolomei, 2003 .

Protective Immunity in BALB / c Mice Induces Brucella abortus Synthase from A DNA Vaccine Encoding Lumazine

M. Spitz, F. Goldbaum, S. Estein, 2002 .

Immunogenicity of recombinant Omp31 from Brucella melitensis in rams and serum bactericidal activity against B. ovis.

F. Paolicchi, S. Estein, J. Cassataro, 2004, Veterinary microbiology.

The recombinant Omp31 from Brucella melitensis alone or associated with rough lipopolysaccharide induces protection against Brucella ovis infection in BALB/c mice.

A. Cloeckaert, M. Zygmunt, N. Vizcaı́no, 2003, Microbes and infection.

Vaccination with the Recombinant Brucella Outer Membrane Protein 31 or a Derived 27-Amino-Acid Synthetic Peptide Elicits a CD4+ T Helper 1 Response That Protects against Brucella melitensis Infection

S. Estein, G. Giambartolomei, J. Cassataro, 2005, Infection and Immunity.

Recent Advances in Understanding Immunity Against Brucellosis: Application for Vaccine Development

Fernanda S. Oliveira, S. Oliveira, Á. Oñate, 2010 .

Omp25‐dependent engagement of SLAMF1 by Brucella abortus in dendritic cells limits acute inflammation and favours bacterial persistence in vivo

J. Gorvel, S. Méresse, Gabriela González-Espinoza, 2020, Cellular microbiology.

abortus Infection in Mice Role in Host Innate Resistance to Brucella Toll-Like Receptor 6 Plays an Important

S. Oliveira, P. P. Corsetti, M. T. Gomes, 2013 .

Targeting Stat3 Induces Senescence in Tumor Cells and Elicits Prophylactic and Therapeutic Immune Responses against Breast Cancer Growth Mediated by NK Cells and CD4+ T Cells

I. Frahm, M. Tkach, W. Béguelin, 2012, The Journal of Immunology.

A COVID-19 vaccine candidate based on SARS-CoV-2 spike protein and immune-stimulating complexes

C. Prieto, J. Cassataro, Agustina Gugliotta, 2023, Applied Microbiology and Biotechnology.

Design and characterization of chimeric Rabies-SARS-CoV-2 virus-like particles for vaccine purposes

C. Prieto, J. Cassataro, Agustina Gugliotta, 2023, Applied Microbiology and Biotechnology.

Bm Delta-pgm, a vaccine for the control of Brucella melitensis with cross-species protective properties.

C. Czibener, D. Comerci, J. Cassataro, 2023, Vaccine.

Brucella abortus Omp19 recombinant protein subcutaneously co-delivered with an antigen enhances antigen-specific T helper 1 memory responses and induces protection against parasite challenge.

F. Frank, G. Giambartolomei, J. Cassataro, 2016, Vaccine.

This information is current as T Cells + and CD 4 CellsBreast Cancer Growth Mediated by NK Therapeutic Immune Responses against Cells and Elicits Prophylactic and Targeting Stat 3 Induces Senescence in Tumor

I. Frahm, M. Tkach, W. Béguelin, 2012 .

Toll-Like Receptor 6 Plays an Important Role in Host Innate Resistance to Brucella abortus Infection in Mice

Aristóbolo Mendes Silva, S. Oliveira, F. V. Marinho, 2013, Infection and Immunity.

SUMO chains depolymerization induces slender to stumpy differentiation in T. brucei bloodstream parasites

V. Alvarez, J. Cassataro, P. A. Iribarren, 2023, bioRxiv.

The polymeric antigen BLSOmp31 confers protection against Brucella ovis infection in rams.

F. Paolicchi, F. Goldbaum, S. Estein, 2009, Vaccine.